CP 55940
CAS: 83002-04-4
Ref. 3D-FD146910
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
- 5-(1,1-Dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol
- (-)-Cp 55940
- 2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol
- 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]phenol
- Phenol, 5-(1,1-dimethylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-, (1α,2β,5α)-(-)-
- phenol, 5-(1,1-dimethylheptyl)-2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-
- phenol, 5-(1,1-dimethylheptyl)-2-[(1S,2R,5S)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-
CP 55940 is a cannabinoid receptor agonist that inhibits acetylcholine release in the brain and has been shown to cause neuronal death. CP 55940 binds to the α7 nicotinic acetylcholine receptor, which is important for memory and learning. The binding of this drug causes an increase in guanine nucleotide-binding protein (G protein) activity by reducing the rate of GTP hydrolysis, leading to inhibition of adenylyl cyclase activity and subsequent decrease in cAMP levels. CP 55940 has significant up-regulation of toll-like receptors following exposure, which leads to an increased immune response. This drug can also cause bowel disease or side effects such as seizures and psychotic symptoms. CP 55940 can interact with other drugs, including cannabinoids that may lead to serious side effects.
Propriedades químicas
Consulta técnica sobre: 3D-FD146910 CP 55940
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.